Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07529327 · ClinicalTrials.gov registry record · NA

Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services

A NA study, sponsored by University of Oregon.

Recruiting
Registry status
NA
Development phase
244
Enrollment target

NCT07529327 is a NA study that is actively recruiting participants, run by University of Oregon. The registered enrollment target is 244 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07529327, a NA study, is actively recruiting participants, sponsored by University of Oregon.

RECRUITING
Registry status
NA
Development phase
244 participants
Enrollment target

Study Summary

The goal of this clinical trial is to test ways to improve early language development among young children of parents with substance use disorder (SUD). Children of parents with SUD are at increased risk for language delays, and early supports may help prevent long-term learning challenges. This study will examine whether adding additional supports to group-based parenting intervention improves child language outcomes compared to the group intervention alone.

Interventions

  • BEHAVIORAL Comilia Group
  • BEHAVIORAL Interaction Review Enhancement
  • BEHAVIORAL Practical Support Enhancement

Trial Details

FieldValue
Enrollment Target 244 participants
Start Date 2026-03-10
Est. Completion 2029-11-30
Phase NA

Sponsor

University of Oregon

63 total trials

What the Registry Record Tells You About NCT07529327

The ClinicalTrials.gov registry entry for NCT07529327 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oregon, which has 63 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Comilia Group is the first listed.

NCT07529327 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07529327 about?

NCT07529327 is a clinical study titled "Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups and Individualized Services". The goal of this clinical trial is to test ways to improve early language development among young children of parents with substance use disorder (SUD). Children of parents with SUD are at increased risk for language delays, and early supports may help prevent long-term learning challenges. This stu...

What is the current status of trial NCT07529327?

This trial is currently recruiting. It is a NA study. The enrollment target is 244 participants. The study started on 2026-03-10. Estimated completion is 2029-11-30.

What interventions are being tested in trial NCT07529327?

The interventions under investigation include: Comilia Group (BEHAVIORAL), Interaction Review Enhancement (BEHAVIORAL), Practical Support Enhancement (BEHAVIORAL).

Who is sponsoring clinical trial NCT07529327?

This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.